scholarly article | Q13442814 |
P50 | author | Martin Hill | Q60668594 |
P2093 | author name string | Giovanni Pacini | |
Katerina Dvorakova | |||
Bela Bendlova | |||
Karel Vondra | |||
Jana Vrbikova | |||
Tereza Grimmichova | |||
P433 | issue | 2 | |
P921 | main subject | polycystic ovary syndrome | Q500816 |
polycystic ovary | Q5547896 | ||
P304 | page(s) | 121-127 | |
P577 | publication date | 2008-05-29 | |
P1433 | published in | European Journal of Endocrinology | Q3060778 |
P1476 | title | Incretin levels in polycystic ovary syndrome | |
P478 | volume | 159 |
Q97521506 | A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome |
Q92785535 | An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity |
Q91780851 | Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome |
Q33624771 | Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies |
Q50351054 | Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment. |
Q33759065 | Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome |
Q99618100 | Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS |
Q51324113 | Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome. |
Q51297056 | Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study. |
Q38208929 | Gastrointestinal hormones and polycystic ovary syndrome |
Q35936659 | Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery |
Q33569169 | Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications |
Q35641060 | Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome |
Q26781127 | Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1 |
Q40836292 | Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome. |
Q35454767 | Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis |
Q50024493 | Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies |
Q39335770 | β cell function and insulin resistance in lean cases with polycystic ovary syndrome. |
Search more.